Veradermics (MANE) Prepaid Assets (2024 - 2026)
Veradermics' (MANE) quarterly Prepaid Assets came in at $602000.0 in Q1 2026, down 94.34% on a QoQ basis from $10.6 million in Q4 2025.
Analysis
Veradermics (MANE) Prepaid Assets (2024 - 2026) Analysis & Trends
Veradermics (MANE) has 3 years of Prepaid Assets data on file, last reported at $602000.0 in Q1 2026.
- Quarterly Prepaid Assets changed N/A year-over-year to $602000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $602000.0 (changed N/A YoY) and the FY2025 annual result came in at $10.6 million, up 27878.95% from the prior year.
- Prepaid Assets fell to $602000.0 in Q1 2026, from $10.6 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $10.6 million in Q4 2025 to a low of $38000.0 in Q4 2024.
- A 3-year average of $3.8 million and a median of $602000.0 in 2026 frame the typical range for Prepaid Assets.
- The widest YoY moves for Prepaid Assets: up 27878.95% in 2025, down 27878.95% in 2025.
- Tracing MANE's Prepaid Assets over 3 years: stood at $38000.0 in 2024, then soared by 27878.95% to $10.6 million in 2025, then plunged by 94.34% to $602000.0 in 2026.
- The last three Prepaid Assets figures came in at $602000.0 (Q1 2026), $10.6 million (Q4 2025), and $38000.0 (Q4 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Veradermics | 3.96 Bn | 3.96 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.85 Mn |
| Mar 31, 2026 | 6.27 Mn |
| Dec 31, 2025 | 10.63 Mn |
| Dec 31, 2024 | 2.45 Mn |